These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34820745)

  • 21. Cognitive profile and 18F-fluorodeoxyglucose PET study in LRRK2-related Parkinson's disease.
    De Rosa A; Peluso S; De Lucia N; Russo P; Annarumma I; Esposito M; Manganelli F; Brunetti A; De Michele G; Pappatà S
    Parkinsonism Relat Disord; 2018 Feb; 47():80-83. PubMed ID: 29249679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroanatomical changes in early Parkinson's disease with mild cognitive impairment: a VBM study; the Parkinson's Disease Cognitive Impairment Study (PaCoS).
    Donzuso G; Monastero R; Cicero CE; Luca A; Mostile G; Giuliano L; Baschi R; Caccamo M; Gagliardo C; Palmucci S; Zappia M; Nicoletti A
    Neurol Sci; 2021 Sep; 42(9):3723-3731. PubMed ID: 33447925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline.
    Eliassen CF; Reinvang I; Selnes P; Grambaite R; Fladby T; Hessen E
    Brain Behav; 2017 Sep; 7(9):e00776. PubMed ID: 28948074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of striatal dopaminergic neuronal integrity with cognitive dysfunction and cerebral cortical metabolism in Parkinson's disease with mild cognitive impairment.
    Kim H; Oh M; Oh JS; Moon H; Chung SJ; Lee CS; Kim JS
    Nucl Med Commun; 2019 Dec; 40(12):1216-1223. PubMed ID: 31584466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cortical hypometabolism assessed by a metabolic ratio in Parkinson's disease primarily reflects cognitive deterioration-[18F]FDG-PET.
    Liepelt I; Reimold M; Maetzler W; Godau J; Reischl G; Gaenslen A; Herbst H; Berg D
    Mov Disord; 2009 Jul; 24(10):1504-11. PubMed ID: 19489069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Freezing of gait in Parkinson's disease: functional neuroimaging studies of the frontal lobe.
    Gallardo MJ; Cabello JP; Corrales MJ; Torres-Donaire J; Bravo JJ; Talavera MP; León A; Vaamonde-Gamo J
    Neurol Res; 2018 Oct; 40(10):900-905. PubMed ID: 29985119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced lateral occipital gray matter volume is associated with physical frailty and cognitive impairment in Parkinson's disease.
    Chen YS; Chen HL; Lu CH; Chen MH; Chou KH; Tsai NW; Yu CC; Chiang PL; Lin WC
    Eur Radiol; 2019 May; 29(5):2659-2668. PubMed ID: 30523452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beyond PD-MCI: objectively defined subtle cognitive decline predicts future cognitive and functional changes.
    Jones JD; Uribe C; Bunch J; Thomas KR
    J Neurol; 2021 Jan; 268(1):337-345. PubMed ID: 32804281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radionuclide brain imaging correlates of cognitive impairment in Parkinson's disease (PD).
    Nobili F; Morbelli S; Arnaldi D; Ferrara M; Campus C; Brugnolo A; Mazzei D; Mehrdad N; Sambuceti G; Rodriguez G
    J Neurol Sci; 2011 Nov; 310(1-2):31-5. PubMed ID: 21762928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific pattern of linguistic impairment in Parkinson's disease patients with subjective cognitive decline and mild cognitive impairment predicts dementia.
    Galtier I; Nieto A; Mata M; Lorenzo JN; Barroso J
    J Int Neuropsychol Soc; 2023 Aug; 29(7):632-640. PubMed ID: 36226685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analyses of Visuospatial and Visuoperceptual Errors as Predictors of Dementia in Parkinson's Disease Patients with Subjective Cognitive Decline and Mild Cognitive Impairment.
    Galtier I; Nieto A; Mata M; Lorenzo JN; Barroso J
    J Int Neuropsychol Soc; 2021 Aug; 27(7):722-732. PubMed ID: 33303048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered Cholinergic Innervation in De Novo Parkinson's Disease with and Without Cognitive Impairment.
    van der Zee S; Kanel P; Gerritsen MJJ; Boertien JM; Slomp AC; Müller MLTM; Bohnen NI; Spikman JM; van Laar T
    Mov Disord; 2022 Apr; 37(4):713-723. PubMed ID: 35037719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FDG PET Parkinson's disease-related pattern as a biomarker for clinical trials in early stage disease.
    Matthews DC; Lerman H; Lukic A; Andrews RD; Mirelman A; Wernick MN; Giladi N; Strother SC; Evans KC; Cedarbaum JM; Even-Sapir E
    Neuroimage Clin; 2018; 20():572-579. PubMed ID: 30186761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Association of β-Amyloid with Cognition and Striatal Dopamine in Early, Non-Demented Parkinson's Disease.
    Oh YS; Yoo SW; Lyoo CH; Yoo JY; Yoon H; Ha S; Lee KS; Kim JS
    J Parkinsons Dis; 2021; 11(2):605-613. PubMed ID: 33646180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural and metabolic correlates of neuropsychological profiles in multiple system atrophy and Parkinson's disease.
    Kübler D; Kobylecki C; McDonald KR; Anton-Rodriguez JM; Herholz K; Carter SF; Hinz R; Thompson JC; Al-Fatly B; Gerhard A
    Parkinsonism Relat Disord; 2023 Feb; 107():105277. PubMed ID: 36621156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Statistical parametric mapping analysis of
    Chu JS; Liu TH; Zang YZ; Wang KL; Ma HZ; Han CL; Zhao XB; Liu YP; Xia XT; Meng FG
    Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(33):2632-2635. PubMed ID: 30220149
    [No Abstract]   [Full Text] [Related]  

  • 37. Visual hallucinations and cognitive impairment in Parkinson's disease.
    Park HK; Kim JS; Im KC; Kim MJ; Lee JH; Lee MC; Kim J; Chung SJ
    Can J Neurol Sci; 2013 Sep; 40(5):657-62. PubMed ID: 23968938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subjective Cognitive Decline in Women with Features Suggestive of Prodromal Parkinson's Disease.
    Flores-Torres MH; Bjornevik K; Hung AY; Healy BC; Schwarzschild MA; Blacker D; Ascherio A
    Mov Disord; 2023 Aug; 38(8):1473-1482. PubMed ID: 37315105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Importance of Balance-Gait Disorder as a Risk Factor for Cognitive Impairment, Dementia and Related Non-Motor Symptoms in Parkinson's Disease.
    Lichter DG; Benedict RHB; Hershey LA
    J Parkinsons Dis; 2018; 8(4):539-552. PubMed ID: 30124451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Effect of Education on Memory-Encoding Activation in Subjective Cognitive Decline.
    Mizuno A; Karim HT; Ly MJ; Cohen AD; Lopresti BJ; Mathis CA; Klunk WE; Aizenstein HJ; Snitz BE
    J Alzheimers Dis; 2021; 81(3):1065-1078. PubMed ID: 33843669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.